Quarterly report pursuant to Section 13 or 15(d)

SHARE BASED COMPENSATION (Details)

v3.4.0.3
SHARE BASED COMPENSATION (Details) - Restricted Stock
3 Months Ended
Mar. 31, 2016
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Non-vested, beginning balance, shares | shares 311,372,000
Vested, shares | shares (128,111,000)
Forfeited, shares | shares (1,620,000)
Non-vested, ending balance, shares | shares 521,554,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Non-vested, beginning balance, Weighted Average Grant Price (USD per share) | $ / shares $ 22.58
Vested, Weighted Average Grant Price (USD per shares) | $ / shares 22.44
Forfeited, Weighted Average Grant Price (USD per share) | $ / shares 25.15
Non-vested, ending balance, Weighted Average Grant Price (USD per share) | $ / shares $ 14.79
Non-employee directors  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Restricted stock awards granted, shares | shares 40,663,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Restricted stock awards granted Weighted Average Grant Price (USD per share) | $ / shares $ 10.59
Employees  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Restricted stock awards granted, shares | shares 299,250,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Restricted stock awards granted Weighted Average Grant Price (USD per share) | $ / shares $ 10.59